- Home
- ARWR vs ASR Comparison
ARWR vs ASR Comparison
Compare ARWR & ASR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARWR | ASR |
|---|---|---|
| Founded | 2003 | 1996 |
| Country | United States | Mexico |
| Employees | N/A | 1936 |
| Industry | Biotechnology: Pharmaceutical Preparations | Aerospace |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1B | 9.9B |
| IPO Year | 2009 | N/A |
Fundamental Metrics
Financial Performance| Metric | ARWR | ASR |
|---|---|---|
| Price | $58.19 | $333.22 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 4 |
| Target Price | $81.50 | ★ $365.00 |
| AVG Volume (30 Days) | ★ 1.9M | 58.8K |
| Earning Date | 05-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.28% |
| EPS Growth | ★ 99.80 | N/A |
| EPS | ★ 0.22 | N/A |
| Revenue | ★ $16,142,321.00 | N/A |
| Revenue This Year | N/A | $7.13 |
| Revenue Next Year | N/A | $8.74 |
| P/E Ratio | $269.95 | ★ $18.58 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.66 | $249.21 |
| 52 Week High | $76.76 | $381.52 |
Technical Indicators
Market Signals| Indicator | ARWR | ASR |
|---|---|---|
| Relative Strength Index (RSI) | 36.19 | 39.75 |
| Support Level | $36.34 | $317.85 |
| Resistance Level | $66.37 | $348.98 |
| Average True Range (ATR) | 3.00 | 12.80 |
| MACD | -0.49 | -4.62 |
| Stochastic Oscillator | 13.32 | 17.21 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About ASR Grupo Aeroportuario del Sureste S.A. de C.V.
Grupo Aeroportuario del Sureste SAB de CV and its subsidiaries hold concessions to operate, maintain, and develop airports in the southeast region of Mexico. As an operator of airports, it charges airlines, passengers, and other users fees for using the airports' facilities. The group also derives rental and other income from commercial activities conducted at its airports, such as the leasing of space to restaurants and retailers. The group's operating segments are Cancun, which generates maximum revenue, Aerostar, Airplan, Merida, Villahermosa, Holding and Services, and Others.